Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.PACB · Entity 5650 | EVP, CFO and PAO | February 19, 2020 | February 26, 2020 |
| SANMINA CORPSANM · Entity 3522 | Director | March 16, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Report date February 19, 2020 · Filed February 26, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 874,812 |
Reported balance
After 2020-02-19 transaction · row 1
1 source rowRow 1 · 2020-02-19 · Sale · Disposed 12,558 · Balance 874,812 F1: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and awards.
SANMINA CORP
Report date March 16, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,638 |
Reported balance
After 2026-03-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-16 · Grant · Acquired 1,536 · Balance 9,638 F1: Each restricted stock unit represents a contingent right to receive one share of Sanmina Corporation common stock. F2: The restricted stock units vest in four equal quarterly installments from date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Sanmina Corporation common stock.
F2: The restricted stock units vest in four equal quarterly installments from date of grant.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INTUITIVE SURGICAL INC
Report date November 11, 2005 · Filed December 02, 2005 · Amendment
Section 16 reporting ended · disclosed 2005-12-02. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 110,236 |
Reported balance
After 2005-11-11 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2005-11-11 · Exercise / conversion · Acquired 10,000 · Balance 110,236 F1: The purpose of this amendment is to (a) correctly report report the relationship of the reporting person at the time of the transactions reported in original Form 4 filed with the Securities and Exhange Commission 11/15/2005 (b) correctly report the number of shares exercised in the original Form 4 filed with the Securities and Exhange Commission 11/15/2005 and (c) correctly report the sale price and number of shares sold of the issuer's common stock owned by the reporting person following the transactions reported in the original Form 4 filed with the Securities and Exchange Commission on 11/15/2005. |
| Common StockSEC Table I · non-derivative | Direct | 112,736 |
Reported balance
After 2005-11-11 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2005-11-11 · Exercise / conversion · Acquired 2,500 · Balance 112,736 |
| Common StockSEC Table I · non-derivative | Direct | 136,975 |
Reported balance
After 2005-11-11 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2005-11-11 · Exercise / conversion · Acquired 24,239 · Balance 136,975 |
| Common StockSEC Table I · non-derivative | Direct | 155,236 |
Reported balance
After 2005-11-11 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2005-11-11 · Exercise / conversion · Acquired 18,261 · Balance 155,236 |
| Common StockSEC Table I · non-derivative | Direct | 162,267 |
Reported balance
After 2005-11-11 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2005-11-11 · Exercise / conversion · Acquired 7,031 · Balance 162,267 |
| Common StockSEC Table I · non-derivative | Direct | 162,736 |
Reported balance
After 2005-11-11 transaction · row 6
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 6 · 2005-11-11 · Exercise / conversion · Acquired 469 · Balance 162,736 |
| Common StockSEC Table I · non-derivative | Direct | 209,348 |
Reported balance
After 2005-11-11 transaction · row 8
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 8 · 2005-11-11 · Exercise / conversion · Acquired 11,457 · Balance 209,348 |
| Common StockSEC Table I · non-derivative | Direct | 243,723 |
Reported balance
After 2005-11-11 transaction · row 9
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 9 · 2005-11-11 · Exercise / conversion · Acquired 34,375 · Balance 243,723 |
| Common StockSEC Table I · non-derivative | Direct | 260,389 |
Reported balance
After 2005-11-11 transaction · row 10
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 10 · 2005-11-11 · Exercise / conversion · Acquired 16,666 · Balance 260,389 |
| Common StockSEC Table I · non-derivative | Direct | 266,222 |
Reported balance
After 2005-11-11 transaction · row 11
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 11 · 2005-11-11 · Exercise / conversion · Acquired 5,833 · Balance 266,222 F1: The purpose of this amendment is to (a) correctly report report the relationship of the reporting person at the time of the transactions reported in original Form 4 filed with the Securities and Exhange Commission 11/15/2005 (b) correctly report the number of shares exercised in the original Form 4 filed with the Securities and Exhange Commission 11/15/2005 and (c) correctly report the sale price and number of shares sold of the issuer's common stock owned by the reporting person following the transactions reported in the original Form 4 filed with the Securities and Exchange Commission on 11/15/2005. |
| Common StockSEC Table I · non-derivative | Direct | 261,222 |
Reported balance
After 2005-11-11 transaction · row 12
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 12 · 2005-11-11 · Sale · Disposed 5,000 · Balance 261,222 |
| Common StockSEC Table I · non-derivative | Direct | 253,722 |
Reported balance
After 2005-11-11 transaction · row 13
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 13 · 2005-11-11 · Sale · Disposed 7,500 · Balance 253,722 F1: The purpose of this amendment is to (a) correctly report report the relationship of the reporting person at the time of the transactions reported in original Form 4 filed with the Securities and Exhange Commission 11/15/2005 (b) correctly report the number of shares exercised in the original Form 4 filed with the Securities and Exhange Commission 11/15/2005 and (c) correctly report the sale price and number of shares sold of the issuer's common stock owned by the reporting person following the transactions reported in the original Form 4 filed with the Securities and Exchange Commission on 11/15/2005. |
| Common StockSEC Table I · non-derivative | Direct | 223,722 |
Reported balance
After 2005-11-11 transaction · row 14
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 14 · 2005-11-11 · Sale · Disposed 30,000 · Balance 223,722 |
| Common StockSEC Table I · non-derivative | Direct | 218,722 |
Reported balance
After 2005-11-11 transaction · row 15
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 15 · 2005-11-11 · Sale · Disposed 5,000 · Balance 218,722 |
| Common StockSEC Table I · non-derivative | Direct | 211,222 |
Reported balance
After 2005-11-11 transaction · row 16
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 16 · 2005-11-11 · Sale · Disposed 7,500 · Balance 211,222 |
| Common StockSEC Table I · non-derivative | Direct | 207,722 |
Reported balance
After 2005-11-11 transaction · row 17
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 17 · 2005-11-11 · Sale · Disposed 3,500 · Balance 207,722 |
| Common StockSEC Table I · non-derivative | Direct | 202,722 |
Reported balance
After 2005-11-11 transaction · row 18
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 18 · 2005-11-11 · Sale · Disposed 5,000 · Balance 202,722 |
| Common StockSEC Table I · non-derivative | Direct | 198,722 |
Reported balance
After 2005-11-11 transaction · row 19
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 19 · 2005-11-11 · Sale · Disposed 4,000 · Balance 198,722 |
| Common StockSEC Table I · non-derivative | Direct | 188,722 |
Reported balance
After 2005-11-11 transaction · row 20
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 20 · 2005-11-11 · Sale · Disposed 10,000 · Balance 188,722 |
| Common StockSEC Table I · non-derivative | Direct | 173,722 |
Reported balance
After 2005-11-11 transaction · row 21
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 21 · 2005-11-11 · Sale · Disposed 15,000 · Balance 173,722 |
| Common StockSEC Table I · non-derivative | Direct | 169,451 |
Reported balance
After 2005-11-11 transaction · row 22
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 22 · 2005-11-11 · Sale · Disposed 4,271 · Balance 169,451 F1: The purpose of this amendment is to (a) correctly report report the relationship of the reporting person at the time of the transactions reported in original Form 4 filed with the Securities and Exhange Commission 11/15/2005 (b) correctly report the number of shares exercised in the original Form 4 filed with the Securities and Exhange Commission 11/15/2005 and (c) correctly report the sale price and number of shares sold of the issuer's common stock owned by the reporting person following the transactions reported in the original Form 4 filed with the Securities and Exchange Commission on 11/15/2005. |
| Common StockSEC Table I · non-derivative | Direct | 161,951 |
Reported balance
After 2005-11-11 transaction · row 23
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 23 · 2005-11-11 · Sale · Disposed 7,500 · Balance 161,951 |
| Common StockSEC Table I · non-derivative | Direct | 156,951 |
Reported balance
After 2005-11-11 transaction · row 24
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 24 · 2005-11-11 · Sale · Disposed 5,000 · Balance 156,951 |
| Common StockSEC Table I · non-derivative | Direct | 153,451 |
Reported balance
After 2005-11-11 transaction · row 25
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 25 · 2005-11-11 · Sale · Disposed 3,500 · Balance 153,451 |
| Common StockSEC Table I · non-derivative | Direct | 141,951 |
Reported balance
After 2005-11-11 transaction · row 26
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 26 · 2005-11-11 · Sale · Disposed 11,500 · Balance 141,951 |
| Common StockSEC Table I · non-derivative | Direct | 136,951 |
Reported balance
After 2005-11-11 transaction · row 27
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 27 · 2005-11-11 · Sale · Disposed 5,000 · Balance 136,951 |
| Common StockSEC Table I · non-derivative | Direct | 131,951 |
Reported balance
After 2005-11-11 transaction · row 28
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 28 · 2005-11-11 · Sale · Disposed 5,000 · Balance 131,951 |
| Common StockSEC Table I · non-derivative | Direct | 126,236 |
Reported balance
After 2005-11-11 transaction · row 29
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 29 · 2005-11-11 · Sale · Disposed 5,715 · Balance 126,236 |
| Conmon StockSEC Table I · non-derivative | Direct | 197,891 |
Reported balance
After 2005-11-11 transaction · row 7
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 7 · 2005-11-11 · Exercise / conversion · Acquired 35,155 · Balance 197,891 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.00 · Expires 2009-08-09 | Direct | 10,000 |
Reported balance
After 2005-11-11 transaction · row 30
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 30 · 2005-11-11 · Exercise / conversion · Acquired 10,000 · Balance 10,000 F2: All share option grants are vested. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.00 · Expires 2010-03-17 | Direct | 2,500 |
Reported balance
After 2005-11-11 transaction · row 31
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 31 · 2005-11-11 · Exercise / conversion · Acquired 2,500 · Balance 2,500 F2: All share option grants are vested. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $14.50 · Expires 2010-01-22 | Direct | 24,239 |
Reported balance
After 2005-11-11 transaction · row 32
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 32 · 2005-11-11 · Exercise / conversion · Acquired 24,239 · Balance 24,239 F2: All share option grants are vested. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $14.50 · Expires 2011-01-22 | Direct | 18,261 |
Reported balance
After 2005-11-11 transaction · row 33
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 33 · 2005-11-11 · Exercise / conversion · Acquired 18,261 · Balance 18,261 F2: All share option grants are vested. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $11.38 · Expires 2010-03-22 | Direct | 7,031 |
Reported balance
After 2005-11-11 transaction · row 34
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 34 · 2005-11-11 · Exercise / conversion · Acquired 7,031 · Balance 7,031 F3: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $11.38 · Expires 2012-02-01 | Direct | 469 |
Reported balance
After 2005-11-11 transaction · row 35
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 35 · 2005-11-11 · Exercise / conversion · Acquired 469 · Balance 469 F3: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $18.50 · Expires 2012-03-24 | Direct | 35,155 |
Reported balance
After 2005-11-11 transaction · row 36
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 36 · 2005-11-11 · Exercise / conversion · Acquired 35,155 · Balance 35,155 F3: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $11.74 · Expires 2013-02-06 | Direct | 34,375 |
Reported balance
After 2005-11-11 transaction · row 37
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 37 · 2005-11-11 · Exercise / conversion · Acquired 34,375 · Balance 34,375 F3: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $18.50 · Expires 2014-02-13 | Direct | 16,666 |
Reported balance
After 2005-11-11 transaction · row 38
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 38 · 2005-11-11 · Exercise / conversion · Acquired 16,666 · Balance 16,666 F3: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $47.86 · Expires 2015-02-11 | Direct | 5,833 |
Reported balance
After 2005-11-11 transaction · row 39
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 39 · 2005-11-11 · Exercise / conversion · Acquired 5,833 · Balance 5,833 F1: The purpose of this amendment is to (a) correctly report report the relationship of the reporting person at the time of the transactions reported in original Form 4 filed with the Securities and Exhange Commission 11/15/2005 (b) correctly report the number of shares exercised in the original Form 4 filed with the Securities and Exhange Commission 11/15/2005 and (c) correctly report the sale price and number of shares sold of the issuer's common stock owned by the reporting person following the transactions reported in the original Form 4 filed with the Securities and Exchange Commission on 11/15/2005. F3: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $18.50 · Expires 2012-03-14 | Direct | 11,457 |
Reported balance
After 2005-11-11 transaction · row 40
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 40 · 2005-11-11 · Exercise / conversion · Acquired 11,457 · Balance 11,457 F3: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. |
Filing footnotes · ownership attribution and instrument terms
F1: The purpose of this amendment is to (a) correctly report report the relationship of the reporting person at the time of the transactions reported in original Form 4 filed with the Securities and Exhange Commission 11/15/2005 (b) correctly report the number of shares exercised in the original Form 4 filed with the Securities and Exhange Commission 11/15/2005 and (c) correctly report the sale price and number of shares sold of the issuer's common stock owned by the reporting person following the transactions reported in the original Form 4 filed with the Securities and Exchange Commission on 11/15/2005.
F2: All share option grants are vested.
F3: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2026 Filed Mar 18, 2026 20:05 UTC | SANMINA CORP SANM · Entity 3522 | GrantCommon Stock | 1,536 | $123.69 | $189,987.84 |
DisclosureSEC source: 0001104659-26-030869 · tm269195-1_4seq1.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,638 F1 · security: Each restricted stock unit represents a contingent right to receive one share of Sanmina Corporation common stock. F2 · shares: The restricted stock units vest in four equal quarterly installments from date of grant. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:01 UTC | SANMINA CORP SANM · Entity 3522 | GrantCommon Stock | 2,496 | $76.12 | $189,995.52 |
DisclosureSEC source: 0001104659-25-025537 · tm259704-1_4seq1.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,102 F1 · security: Each restricted stock unit represents a contingent right to receive one share of Sanmina Corporation common stock. F2 · shares: The restricted stock units vest in four equal quarterly installments from date of grant. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:22 UTC | SANMINA CORP SANM · Entity 3522 | GrantCommon Stock | 3,020 | $59.61 | $180,022.20 |
DisclosureSEC source: 0001104659-24-036156 · tm249032-1_4seq1.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,606 F1 · security: Each restricted stock unit represents a contingent right to receive one share of Sanmina Corporation common stock. F2 · shares: The restricted stock units vest in four equal quarterly installments from date of grant. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 20:01 UTC | SANMINA CORP SANM · Entity 3522 | GrantCommon Stock | 2,586 | $52.21 | $135,015.06 |
DisclosureSEC source: 0001104659-23-101932 · tm2326364-2_4seq1.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,586 F1 · security: Each restricted stock unit represents a contingent right to receive one share of Sanmina Corporation common stock. F2 · shares: The restricted stock units vest in four equal quarterly installments from date of grant. Read SEC document |
| February 19, 2020 Filed Feb 26, 2020 00:09 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 12,558 | $4.44 | $55,757.52 |
DisclosureSEC source: 0001209191-20-012763 · doc4.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 874,812 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and awards. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:32 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011085 · doc4.xml · nonDerivative · entry 2 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 887,370 F2 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in two (2) equal annual installments on February 18 of each of 2021 and 2022, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:32 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011085 · doc4.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837,370 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in four (4) equal annual installments on February 18 of each of 2021, 2022, 2023, and 2024, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 01:45 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 11,987 | $7.16 | $85,850.89 |
DisclosureSEC source: 0001209191-19-011848 · doc4.xml · nonDerivative · entry 3 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737,370 F3 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and performance awards. F4 · price: This sale price represents the weighted average sale price of the shares sold ranging from $7.16 to $7.18 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 15, 2019 Filed Feb 21, 2019 01:45 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 19,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011848 · doc4.xml · nonDerivative · entry 2 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 749,357 F2 · shares: Represents the number of shares earned upon satisfaction of performance goals in connection with performance-based restricted stock units. Read SEC document |
| February 15, 2019 Filed Feb 21, 2019 01:45 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 21,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011848 · doc4.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 729,407 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest on the earlier of (i) the first anniversary of the Grant Date, or (ii) the completion of the proposed acquisition of the Issuer by Illumina, Inc., provided that the Reporting Person continues to serve through the vesting date. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:37 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 18,228 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001209191-18-063927 · doc4.xml · derivative · entry 6 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,272 Underlying: Common Stock · 18,228 shares Expires 2028-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:37 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 48,762 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001209191-18-063927 · doc4.xml · derivative · entry 5 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,762 shares Expires 2023-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option were fully vested and exercisable. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:37 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $4.79 | $0.00 |
DisclosureSEC source: 0001209191-18-063927 · doc4.xml · derivative · entry 4 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2022-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option were fully vested and exercisable. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:37 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 18,228 | $2.63 | $47,939.64 |
DisclosureSEC source: 0001209191-18-063927 · doc4.xml · nonDerivative · entry 3 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 708,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:37 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 48,762 | $2.27 | $110,689.74 |
DisclosureSEC source: 0001209191-18-063927 · doc4.xml · nonDerivative · entry 2 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 689,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:37 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 250,000 | $4.79 | $1,197,500.00 |
DisclosureSEC source: 0001209191-18-063927 · doc4.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 641,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:07 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 87,500 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001209191-18-020140 · doc4.xml · derivative · entry 2 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2028-03-15 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:07 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-020140 · doc4.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,167 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15 of each of 2019, 2020, 2021, and 2022, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:20 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 276,238 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001209191-17-038121 · doc4.xml · derivative · entry 2 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,762 Underlying: Common Stock · 276,238 shares Expires 2023-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/60th of the shares subject to the option vest monthly over a five year period, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:20 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 276,238 | $2.27 | $627,060.26 |
DisclosureSEC source: 0001209191-17-038121 · doc4.xml · nonDerivative · entry 1 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 21:03 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $5.27 | $0.00 |
DisclosureSEC source: 0001209191-17-011426 · doc4.xml · derivative · entry 1 BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2027-02-15 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionStock Option · Derivative | 11,457 | $18.50 Strike: $18.50 | $211,954.50 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · derivative · entry 40 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,457 Underlying: Common Stock · 0 shares Expires 2012-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionStock Option · Derivative | 6,562 | $47.86 Strike: $47.86 | $314,057.32 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · derivative · entry 39 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,562 Underlying: Common Stock · 0 shares Expires 2015-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionStock Option · Derivative | 16,666 | $18.50 Strike: $18.50 | $308,321.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · derivative · entry 38 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,666 Underlying: Common Stock · 0 shares Expires 2014-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionStock Option · Derivative | 34,375 | $11.74 Strike: $11.74 | $403,562.50 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · derivative · entry 37 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,375 Underlying: Common Stock · 0 shares Expires 2013-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionStock Option · Derivative | 35,155 | $18.50 Strike: $18.50 | $650,367.50 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · derivative · entry 36 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,155 Underlying: Common Stock · 0 shares Expires 2012-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionStock Option · Derivative | 469 | $11.38 Strike: $11.38 | $5,334.88 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · derivative · entry 35 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469 Underlying: Common Stock · 0 shares Expires 2012-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionStock Option · Derivative | 7,031 | $11.38 Strike: $11.38 | $79,977.63 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · derivative · entry 34 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,031 Underlying: Common Stock · 0 shares Expires 2010-03-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercised shares are fully exercisable; remaining option shares vested at 1/48th of total grant per month. Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionStock Option · Derivative | 18,261 | $14.50 Strike: $14.50 | $264,784.50 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · derivative · entry 33 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,261 Underlying: Common Stock · 0 shares Expires 2011-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All share option grants are vested. Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionStock Option · Derivative | 24,239 | $14.50 Strike: $14.50 | $351,465.50 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · derivative · entry 32 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,239 Underlying: Common Stock · 0 shares Expires 2010-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All share option grants are vested. Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionStock Option · Derivative | 2,500 | $6.00 Strike: $6.00 | $15,000.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · derivative · entry 31 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 0 shares Expires 2010-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All share option grants are vested. Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionStock Option · Derivative | 10,000 | $6.00 Strike: $6.00 | $60,000.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · derivative · entry 30 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 0 shares Expires 2009-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All share option grants are vested. Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 5,715 | $98.90 | $565,213.50 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 29 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,236 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 5,000 | $98.50 | $492,500.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 28 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,951 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 5,000 | $98.47 | $492,350.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 27 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,951 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 11,500 | $98.40 | $1,131,600.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 26 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,951 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 3,500 | $98.35 | $344,225.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 25 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,451 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 5,000 | $98.03 | $490,150.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 24 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,951 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 7,500 | $98.00 | $735,000.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 23 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,951 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 5,000 | $97.77 | $488,850.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 22 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,451 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 15,000 | $97.67 | $1,465,050.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 21 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,451 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 10,000 | $97.53 | $975,300.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 20 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,451 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 4,000 | $97.26 | $389,040.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 19 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,451 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 5,000 | $97.25 | $486,250.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 18 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,451 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 3,500 | $97.24 | $340,340.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 17 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,451 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 7,500 | $97.23 | $729,225.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 16 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,951 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 5,000 | $97.22 | $486,100.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 15 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,451 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 30,000 | $97.20 | $2,916,000.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 14 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,451 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 7,500 | $97.50 | $731,250.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 13 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,451 Read SEC document |
| November 11, 2005 Filed Nov 15, 2005 17:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 5,000 | $97.00 | $485,000.00 |
DisclosureSEC source: 0001209191-05-057362 · doc4.xml · nonDerivative · entry 12 BARNES SUSAN K · CIK 0001267695 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,951 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.